Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin Dosing in Hematological Tumors
NCT04738955Phase 4Unknown
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Feb 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of micafungin in invasive fungal disease (IFD), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Status: unknown.
02
Drugs
micafungin
03
Conditions
invasive fungal disease (IFD)
Beyond the preview
Go deeper on NCT04738955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04738955.